tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market

Biogen (BIIB) Financial Statements

Compare
4,994 Followers

Biogen Financial Overview

Biogen's market cap is currently $27.60B. The company's EPS TTM is $1.99; its P/E ratio is 19.96; Biogen is scheduled to report earnings on February 6, 2026, and the estimated EPS forecast is $3.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 9.81B$ 9.68B$ 9.84B$ 10.17B$ 10.98B
Gross Profit$ 6.91B$ 7.37B$ 7.30B$ 7.90B$ 8.87B
Operating Income$ 1.88B$ 2.49B$ 2.10B$ 2.89B$ 2.79B
EBITDA$ 3.10B$ 3.00B$ 2.38B$ 3.54B$ 3.92B
Net Income$ 1.29B$ 1.63B$ 1.16B$ 3.05B$ 1.56B
Balance Sheet
Cash & Short-Term Investments$ 3.82B$ 2.38B$ 1.05B$ 4.89B$ 3.80B
Total Assets$ 29.44B$ 28.05B$ 26.84B$ 24.55B$ 23.88B
Total Debt$ 6.95B$ 6.63B$ 7.34B$ 6.61B$ 7.60B
Net Debt$ 3.94B$ 4.26B$ 6.29B$ 3.19B$ 5.34B
Total Liabilities$ 11.18B$ 11.33B$ 12.05B$ 11.17B$ 12.92B
Stockholders' Equity$ 18.26B$ 16.72B$ 14.80B$ 13.40B$ 10.90B
Cash Flow
Free Cash Flow$ 2.05B$ 2.52B$ 1.24B$ 1.14B$ 3.38B
Operating Cash Flow$ 2.20B$ 2.88B$ 1.55B$ 1.38B$ 3.64B
Investing Cash Flow$ -1.37B$ -799.20M$ -4.09B$ 1.59B$ -563.70M
Financing Cash Flow$ -301.90M$ -683.50M$ 137.00M$ -1.76B$ -2.09B
Currency in USD

Biogen Earnings and Revenue History

Biogen Debt to Assets

Biogen Cash Flow

Biogen Forecast EPS vs Actual EPS